China Shineway Pharmaceutical Group (HKSE:02877) Accounts Payable & Accrued Expense : HK$989 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is China Shineway Pharmaceutical Group Accounts Payable & Accrued Expense?

China Shineway Pharmaceutical Group's quarterly accounts payable & accrued expense increased from Dec. 2022 (HK$766 Mil) to Jun. 2023 (HK$1,852 Mil) but then declined from Jun. 2023 (HK$1,852 Mil) to Dec. 2023 (HK$989 Mil).

China Shineway Pharmaceutical Group's annual accounts payable & accrued expense declined from Dec. 2021 (HK$1,192 Mil) to Dec. 2022 (HK$766 Mil) but then increased from Dec. 2022 (HK$766 Mil) to Dec. 2023 (HK$989 Mil).

China Shineway Pharmaceutical Group Accounts Payable & Accrued Expense Historical Data

The historical data trend for China Shineway Pharmaceutical Group's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group Accounts Payable & Accrued Expense Chart

China Shineway Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

750.07

876.23

1,192.30

765.63

988.63

China Shineway Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,192.30	1,304.65	765.63	1,851.96	988.63

China Shineway Pharmaceutical Group Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

China Shineway Pharmaceutical Group (HKSE:02877) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (HKSE:02877) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

C1S:Germany

Address

Luan Cheng, Hebei Province, Shijiazhuang, CHN

Website

http://www.shineway.com.hk

China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

Executives

Bh Corporate Services Ltd	2301 Trustee
Bodnar-horvath Kwai Yung Helen	2202 Interest of your spouse
Bodnar-horvath Nicholas Eugene Francis	2201 Interest of corporation controlled by you
Forway Investment Limited	2101 Beneficial owner
Li Zhenjiang	2307 Founder of a discretionary trust who can infl

China Shineway Pharmaceutical Group (HKSE:02877) Headlines

No Headlines